ClinicalTrials.gg
RecruitingNCT04987541Updated Aug 31, 2023

The Therapeutic Effect of TBS Stimulation on Emotion Regulation in Autism Spectrum Disorder

An interventional study of intermittent theta burst stimulation in Autism Spectrum Disorder, sponsored by Chang Gung Memorial Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 8 Years to 30 Years. Per ClinicalTrials.gov, last updated 2023-08-31.

Sponsored by Chang Gung Memorial Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2025, 1 year 2 months ago, but the record still lists the study as recruiting.
  • Started Sep 2022; still recruiting 4 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
8 Years to 30 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital — 5 open to participants now, 7 under way, none of them phase 3. Autism Spectrum Disorder · Chang Gung Memorial Hospital.

Planned enrollment
3rd of 12
60 · median 60
Started
2022
with 2 others
No phase
11 of 15
4 open now
Registered
4th of 15
by date

Among the 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital, this one is the 3rd largest by planned enrollment of the 12 interventional ones that give a count, is one of 3 that started in 2022, is one of 11 with no phase, and was the 4th registered.

Autism Spectrum Disorder

1,733 studies on the registry are indexed under Autism Spectrum Disorder; 503 are open to participants now.

Browse Autism Spectrum Disorder studies →

Open to participants now

5 of the 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 351 Autism Spectrum Disorder studies recruiting now, 48 (14%) set no upper age limit and 296 (84%) stop at 75 or younger; 301 take children under 18; 92 take healthy volunteers.

This study: 8 Years to 30 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Autism Spectrum Disorder by Chang Gung Memorial Hospital, or all of them as a file.
02

Study summary

The investigator would like to investigate the impact of intermittent theta burst stimulation over left dorsolateral prefrontal cortex on emotion regulation in autism spectrum disorder

03

Conditions studied

  • Autism Spectrum Disorder
04

Who can participate

Ages eligible
8 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • autism spectrum disorder, confirmed by ADOS

Exclusion criteria

Exclusion Criteria:

  • Previous or current severe neurological disorder such as epilepsy, visual or hearing impairment
  • Previous or current severe systemic disease such as cardiovascular disease, diabetes or infection
  • Previous or current severe brain injury
  • Implementation of metal materials such as pacemaker or medication pump
  • Previous or current severe psychiatric disorders such as schizophrenia, bipolar disorder or substance abuse
  • Pregnancy
  • Individuals with a significant brain abnormality such as intracranial space occupied lesions
  • Individuals with a family history of epilepsy
  • Previous febrile seizures
  • Current taking antiepileptic drugs
  • Concurrent use of medications which increased the risk of seizure attack
  • Individuals suffering from sleep deprivation during rTMS procedures
  • Skin trauma on application site
  • Any condition which in the Investigator's opinion deems the participant an unsuitable candidate to participate in the study
  • Participate another clinical trial within one month
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    Active

    Participants received the real intervention of TBS (iTBS 600) over the left dorsolateral prefrontal cortex for 4 weeks (5 days/week). \*iTBS = intermittent theta burst stimulation

    Device: intermittent theta burst stimulation

  • Sham comparator
    Sham

    Participants received the sham intervention of TBS (sham-coil) over the left dorsolateral prefrontal cortex for 4 weeks (5 days/week).

    Device: intermittent theta burst stimulation

Interventions

  • Deviceintermittent theta burst stimulation

    stimulatory protocol

06

What researchers measure

Primary outcomes

  1. Changes of total scores of Emotional Dysregulation Inventory

    Emotional Dysregulation Inventory is a parents' report questionnaire for emotional dysregulation. The score ranges from 0-120. The lower scores stand for better emotional regulation.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  2. Changes of total scores of Aberrant Behavior Checklist

    ABC is a parents' report questionnaire for aberrant behavior. The lower scores stand for less aberrant behavior.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  3. Changes of total scores of Child Behavior Checklist

    CBCL is a parents' report questionnaire for behavioral and emotional problems. The lower scores stand for better behavioral and emotional regulation.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

Secondary outcomes

  1. Changes of total scores of Social Responsiveness Scale

    Social Responsiveness Scale can measure the autism clinical severity with the range from 65-260. The lower scores stand for better social responsiveness.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  2. Changes of total scores of Repetitive Behavior Scale-Revised

    Repetitive Behavior Scale-Revised is a questionnaire that focuses on repetitive behavior. The score ranges from 0-129. The lower scores stand for lower repetitive behavior.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  3. Changes of total scores of Adaptive Behavior Assessment System

    Adaptive Behavior Assessment System is a parents' report questionnaire for adaptive behavior. The score ranges from 9-171. The higher scores stand for better adaptive behavior.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  4. Changes in accuracy of Frith-Happe animation

    A quick and objective test of Theory of Mind. 8 questions in total, the more correct questions stand for better Social Cognition.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  5. Changes in accuracy of Eyes task

    An advanced test for Theory of Mind. 43 questions in total, the more correct questions stand for better social skills.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  6. Changes in accuracy of Wisconsin Card Sorting Test

    An advanced test for cognitive flexibility. 128 questions in total, the more correct questions stand for better cognitive flexibility.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  7. Changes of total scores of Behavior Rating Inventory of Executive Function

    Behavior Rating Inventory of Executive Function is a parents' report questionnaire for executive function. The score ranges from 86-258. The lower scores stand for better executive function.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  8. Raven's Progressive Matrices

    An advanced test for for executive function. 60 questions in total, the more correct questions stand for better executive function.

    Time frame: baseline; post TBS (4 weeks after baseline); One month follow up (4 weeks after post TBS); Two months follow up (8 weeks after post TBS)

  9. MRI T1

    Brain structural volumes (cm²)

    Time frame: baseline; post TBS (4 weeks after baseline)

  10. functional MRI (resting-state/biological motion task) - BOLD signal

    Blood-oxygen-level-dependent (BOLD) signal is a measurement used in fMRI, which reflects the neural activity.

    Time frame: baseline; post TBS (4 weeks after baseline)

  11. Diffusion Tensor Imaging (DTI) - FA

    Fractional anisotropy (FA) is a measurement used in DTI, which reflects the movement of water molecules. FA ranges from 0 to 1, the higher FA value may represent more intact axons.

    Time frame: baseline; post TBS (4 weeks after baseline)

  12. Electroencephalography

    Resting state EEG (alpha power / frontal gamma power)

    Time frame: baseline; post TBS (4 weeks after baseline)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2022 (actual). Primary completion is estimated for Sep 2025, 36 months after the start.

Of 806 non-industry interventional studies with no phase under Autism Spectrum Disorder, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 36 months is above that.

Counting every sponsor, half of 829 studies reached it within 25 months; a quarter within 12 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 12, 2021
First posted
Aug 3, 2021
StartActual
Sep 6, 2022
Primary completionEst.
Sep 2025
CompletionEst.
Dec 2025
Last update
Aug 31, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 31, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04987541
Responsible party
Sponsor
First posted
Aug 3, 2021
Start date
Sep 6, 2022
Primary completion
Sep 2025 (estimated)
Completion
Dec 2025 (estimated)
Last update
Aug 31, 2023

Study contacts

Hsing-Chang Ni, Dr.
Contact
alanni0918@yahoo.com.tw
88633281200 ext. 3815

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion